Predict your next investment

Corporation
ascendclinical.com

See what CB Insights has to offer

About Ascend Clinical

Ascend Clinical is a ESRD testing provider for independent dialysis clinics in the United States. LabCheck, LabCheck GO mobile and Ascend Chart deliver a complete suite of clinical services built for independent dialysis clinics.

Ascend Clinical Headquarter Location

1400 Industrial Way

Redwood City, California, 94063,

United States

650-780-5500

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Ascend Clinical News

Ascend To Perform Antibody Testing For COVID-19

Jun 2, 2020

Ascend To Perform Antibody Testing For COVID-19 REDWOOD CITY, Calif., June 1, 2020 /PRNewswire/ -- Ascend, the nation's leading dialysis testing laboratory, has begun performing antibody testing for COVID-19. Author: Jun 1, 2020 11:08 PM EDT REDWOOD CITY, Calif., June 1, 2020 /PRNewswire/ -- Ascend, the nation's leading dialysis testing laboratory, has begun performing antibody testing for COVID-19. Ascend is one of the first to offer COVID-19 total antibody testing on the  Siemens high throughput platform, which can be combined with a patient's regularly scheduled tests. Ascend is using the  SARS-CoV-2 Total Antibody assay from Siemens Healthineers , performed on high throughput Atellica® Solution immunoassay analyzers. The test detects SARS-CoV-2 antibodies with a demonstrated 100 percent sensitivity and 99.8 percent specificity, exceeding stringent FDA quality guidelines. This total antibody test allows for early identification of patients infected with the virus who have developed an adaptive immune response. Siemens received authorization for the test by the FDA under an Emergency Use Authorization (EUA). Initially, the laboratory will be able to process up to 10,000 tests per day with the ability to expand to 50,000 shortly. Ascend expects to report antibody test results within 24 hours of specimen receipt. About Ascend ClinicalFounded in 1984, Ascend Clinical is the leader in end-stage renal disease (ESRD) laboratory testing services for independent and hospital-based dialysis clinics throughout the United States. Media Contact: Thomas Hyland 650-780-5512 hylandt@aclab.com View original content: http://www.prnewswire.com/news-releases/ascend-to-perform-antibody-testing-for-covid-19-301068940.html

Ascend Clinical Acquisitions

1 Acquisition

Ascend Clinical acquired 1 company. Their latest acquisition was PathCentral - Diagnostic Laboratory on December 21, 2012.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

12/21/2012

Acquired Unit

1

Date

12/21/2012

Investment Stage

Companies

Valuation

Total Funding

Note

Acquired Unit

Sources

1

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.